144 related articles for article (PubMed ID: 25694384)
1. Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin.
Feldkamp MD; Gakhar L; Pandey N; Shea MA
Proteins; 2015 May; 83(5):989-96. PubMed ID: 25694384
[TBL] [Abstract][Full Text] [Related]
2. Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin.
Feldkamp MD; O'Donnell SE; Yu L; Shea MA
Proteins; 2010 Aug; 78(10):2265-82. PubMed ID: 20544963
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation of the calmodulin-trifluoperazine complex in aqueous solution.
Yamaotsu N; Suga M; Hirono S
Biopolymers; 2001 Apr; 58(4):410-21. PubMed ID: 11180054
[TBL] [Abstract][Full Text] [Related]
4. Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex.
Cook WJ; Walter LJ; Walter MR
Biochemistry; 1994 Dec; 33(51):15259-65. PubMed ID: 7803388
[TBL] [Abstract][Full Text] [Related]
5. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
Matsushima N; Hayashi N; Jinbo Y; Izumi Y
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
[TBL] [Abstract][Full Text] [Related]
6. Markov state modelling reveals heterogeneous drug-inhibition mechanism of Calmodulin.
Westerlund AM; Sridhar A; Dahl L; Andersson A; Bodnar AY; Delemotte L
PLoS Comput Biol; 2022 Oct; 18(10):e1010583. PubMed ID: 36206305
[TBL] [Abstract][Full Text] [Related]
7. Mediating molecular recognition by methionine oxidation: conformational switching by oxidation of methionine in the carboxyl-terminal domain of calmodulin.
Anbanandam A; Bieber Urbauer RJ; Bartlett RK; Smallwood HS; Squier TC; Urbauer JL
Biochemistry; 2005 Jul; 44(27):9486-96. PubMed ID: 15996103
[TBL] [Abstract][Full Text] [Related]
8. Interaction of antagonists with calmodulin: insights from molecular dynamics simulations.
Kövesi I; Menyhárd DK; Laberge M; Fidy J
J Med Chem; 2008 Jun; 51(11):3081-93. PubMed ID: 18459732
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor and peptide binding to calmodulin characterized by high pressure Fourier transform infrared spectroscopy and Förster resonance energy transfer.
Cinar S; Czeslik C
Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):617-623. PubMed ID: 29555454
[TBL] [Abstract][Full Text] [Related]
10. Complexes formed between calmodulin and the antagonists J-8 and TFP in solution.
Craven CJ; Whitehead B; Jones SK; Thulin E; Blackburn GM; Waltho JP
Biochemistry; 1996 Aug; 35(32):10287-99. PubMed ID: 8756684
[TBL] [Abstract][Full Text] [Related]
11. A high pressure study of calmodulin-ligand interactions using small-angle X-ray and elastic incoherent neutron scattering.
Cinar S; Al-Ayoubi S; Sternemann C; Peters J; Winter R; Czeslik C
Phys Chem Chem Phys; 2018 Jan; 20(5):3514-3522. PubMed ID: 29336441
[TBL] [Abstract][Full Text] [Related]
12. Trifluoperazine-induced conformational change in Ca(2+)-calmodulin.
Vandonselaar M; Hickie RA; Quail JW; Delbaere LT
Nat Struct Biol; 1994 Nov; 1(11):795-801. PubMed ID: 7634090
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and docking studies of gigantol analogs as calmodulin inhibitors.
Reyes-Ramírez A; Leyte-Lugo M; Figueroa M; Serrano-Alba T; González-Andrade M; Mata R
Eur J Med Chem; 2011 Jul; 46(7):2699-708. PubMed ID: 21514702
[TBL] [Abstract][Full Text] [Related]
14. Trifluoperazine regulation of calmodulin binding to Fas: a computational study.
Pan D; Yan Q; Chen Y; McDonald JM; Song Y
Proteins; 2011 Aug; 79(8):2543-56. PubMed ID: 21656570
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies.
Vertessy BG; Harmat V; Böcskei Z; Náray-Szabó G; Orosz F; Ovádi J
Biochemistry; 1998 Nov; 37(44):15300-10. PubMed ID: 9799490
[TBL] [Abstract][Full Text] [Related]
16. Interaction of trifluoperazine with Tetrahymena calmodulin. A 19F NMR study.
Shimizu T; Hatano M; Muto Y; Nozawa Y
FEBS Lett; 1984 Jan; 166(2):373-7. PubMed ID: 6420195
[TBL] [Abstract][Full Text] [Related]
17. Comparison of negative and positive ion electrospray ionization mass spectra of calmodulin and its complex with trifluoperazine.
Watt SJ; Oakley A; Sheil MM; Beck JL
Rapid Commun Mass Spectrom; 2005; 19(15):2123-30. PubMed ID: 15988725
[TBL] [Abstract][Full Text] [Related]
18. EPR and CD spectroscopy of fast myosin light chain conformation during binding of trifluoperazine.
Huang W; Wilson GJ; Brown LJ; Lam H; Hambly BD
Eur J Biochem; 1998 Oct; 257(2):457-65. PubMed ID: 9826193
[TBL] [Abstract][Full Text] [Related]
19. Identification and inhibitory properties of a novel Ca(2+)/calmodulin antagonist.
Colomer J; Schmitt AA; Toone EJ; Means AR
Biochemistry; 2010 May; 49(19):4244-54. PubMed ID: 20392081
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazines inhibit S100A4 function by inducing protein oligomerization.
Malashkevich VN; Dulyaninova NG; Ramagopal UA; Liriano MA; Varney KM; Knight D; Brenowitz M; Weber DJ; Almo SC; Bresnick AR
Proc Natl Acad Sci U S A; 2010 May; 107(19):8605-10. PubMed ID: 20421509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
